Valuation: Burning Rock Biotech Limited

Market Cap 765M 115M 103M 94.7M 85.81M 160M 10.92B 163M 1.13B 453M 5.74B 431M 422M 18.11B P/E 2024
-1.46x
P/E 2025 -27.1x
Enterprise Value 327M 49.2M 44.06M 40.53M 36.72M 68.64M 4.67B 69.93M 483M 194M 2.46B 185M 181M 7.75B EV / Sales 2024
0.06x
EV / Sales 2025 2x
Free-Float
96.23%
Yield 2024 *
-
Yield 2025 -
1 day-1.36%
1 week-17.74%
Current month-38.17%
1 month-42.45%
3 months+23.58%
6 months-32.88%
Current year-45.91%
1 week 10.29
Extreme 10.29
13.1
1 month 10.29
Extreme 10.29
18.01
Current year 6.79
Extreme 6.79
41.72
1 year 6.79
Extreme 6.79
41.72
3 years 2.18
Extreme 2.18
41.72
5 years 2.18
Extreme 2.18
176.65
10 years 2.18
Extreme 2.18
397.5
Manager TitleAgeSince
Corporate Officer/Principal - 01/01/2014
Chief Executive Officer 48 01/01/2014
Director of Finance/CFO - 27/09/2024
Director TitleAgeSince
Chairman 48 -
Director/Board Member 55 01/06/2014
Director/Board Member 63 01/08/2016
Date Insider Type Main position Quantity % Market Cap. Importance
31/3/26 Buy

Chief Executive Officer

314,870 0.3584%
18/3/26
Northern Light Venture Capital Development Ltd.
OtherCompany 11,880,245 13.5213%
17/3/26 Other

Director

22,718 0.0259%
Change 5-day change 1-year change 3-year change Capi.($)
-1.36%-17.74%-12.97%+3.32% 117M
-0.09%-4.48%+11.97%+36.14% 116B
-1.02%+1.26%+1.02%+110.04% 104B
-4.98%+3.22%+114.87%+982.85% 62.85B
-1.84%+9.54%+45.64%+81.64% 29.89B
+0.96%+3.74%-7.04%+92.23% 29.55B
-0.43%+3.51%+44.08%+97.23% 27.83B
+0.99%+0.97%+30.65%+414.40% 21.79B
-0.72%+5.53%-18.98%-7.55% 20.66B
0.00%-1.75%-4.85%+31.49% 17.09B
Average -0.76%+1.12%+20.44%+184.18% 42.88B
Weighted average by Cap. -0.78%+2.03%+26.31%+220.65%

Financials

2024 2025
Net sales 516M 77.5M 69.41M 63.84M 57.85M 108M 7.36B 110M 761M 306M 3.87B 291M 285M 12.21B 540M 81.07M 72.6M 66.78M 60.51M 113M 7.7B 115M 796M 320M 4.05B 304M 298M 12.77B
Net income -347M -52.08M -46.64M -42.9M -38.87M -72.66M -4.94B -74.02M -512M -205M -2.6B -195M -191M -8.2B -55.35M -8.32M -7.45M -6.85M -6.21M -11.6M -790M -11.82M -81.69M -32.79M -415M -31.21M -30.54M -1.31B
Net Debt -474M -71.17M -63.74M -58.63M -53.12M -99.3M -6.76B -101M -699M -281M -3.55B -267M -261M -11.21B -438M -65.76M -58.89M -54.17M -49.08M -91.75M -6.24B -93.47M -646M -259M -3.28B -247M -242M -10.36B
Projected Income Statement - Annual - Burning Rock Biotech Limited
Logo Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a Company principally engaged in developing and providing cancer therapy selection tests. The Company operates three businesses, including central laboratory business, in-hospital business and pharma research and development services. Central laboratory business mainly includes the sales of its cancer therapy selection test to individual patient customers. In-hospital business includes the manufacture and sales of reagent kits, as well as the provision of facilitation services for laboratory equipment sold to hospitals. The pharma research and development services include a range of cancer therapy selection test services, analytical validation services and project management services.
Employees
-
Date Price Change Volume
31/10/26 US$10.90 -1.36% 12,158
29/10/26 US$11.05 -9.87% 29,808
28/10/26 US$12.26 +3.29% 17,712
27/10/26 US$11.87 +6.46% 19,555
26/10/26 US$11.15 -5.67% 28,087